101 related articles for article (PubMed ID: 11096451)
1. Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia.
Bruserud O; Ulvestad E
J Interferon Cytokine Res; 2000 Nov; 20(11):947-54. PubMed ID: 11096451
[TBL] [Abstract][Full Text] [Related]
2. The cellular immune system of patients with acute leukemia and severe chemotherapy-induced leukopenia: characterization of T lymphocyte subsets responsive to IL-16 and IL-17.
Bruserud O; von Volkman HL; Ulvestad E
Acta Haematol; 2000; 104(2-3):80-91. PubMed ID: 11154979
[TBL] [Abstract][Full Text] [Related]
3. Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells.
Bruserud O
Int J Immunopharmacol; 2000 Jan; 22(1):69-81. PubMed ID: 10684990
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 (IL-7) in patients receiving intensive chemotherapy for acute myelogenous leukemia: studies of systemic IL-7 Levels and IL-7 responsiveness of circulating T lymphocytes.
Wendelbo Ø; Glenjen N; Bruserud Ø
J Interferon Cytokine Res; 2002 Oct; 22(10):1057-65. PubMed ID: 12433286
[TBL] [Abstract][Full Text] [Related]
5. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
Bruserud O; Ulvestad E
J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
[TBL] [Abstract][Full Text] [Related]
6. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia.
Wendelbo Ø; Nesthus I; Sjo M; Paulsen K; Ernst P; Bruserud Ø
Cancer Immunol Immunother; 2004 Aug; 53(8):740-7. PubMed ID: 15133630
[TBL] [Abstract][Full Text] [Related]
8. Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts; studies of normal polyclonal T cells and T lymphocyte clones derived early after allogenic bone marrow transplantation.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1996 Mar; 42(3):133-40. PubMed ID: 8640841
[TBL] [Abstract][Full Text] [Related]
9. Human acute lymphoblastic leukemia (ALL) blasts as accessory cells during T-cell activation: differences between patients in costimulatory capacity affect proliferative responsiveness and cytokine release by activated T cells.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2003 Apr; 52(4):215-25. PubMed ID: 12669246
[TBL] [Abstract][Full Text] [Related]
10. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
Ersvaer E; Hampson P; Hatfield K; Ulvestad E; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Cancer Immunol Immunother; 2007 Jun; 56(6):913-25. PubMed ID: 17115221
[TBL] [Abstract][Full Text] [Related]
11. T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: characterization of clonogenic T-cell proliferation.
Bruserud O; Ulvestad E; Berentsen S; Bergheim J; Nesthus I
Scand J Immunol; 1998 Jan; 47(1):54-62. PubMed ID: 9467659
[TBL] [Abstract][Full Text] [Related]
12. Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia.
Bruserud O
Int Immunopharmacol; 2001 Nov; 1(12):2183-95. PubMed ID: 11710547
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-13 secretion by normal and posttransplant T lymphocytes; in vitro studies of cellular immune responses in the presence of acute leukaemia blast cells.
Bruserud O; Pawelec G
Cancer Immunol Immunother; 1997 Oct; 45(1):45-52. PubMed ID: 9353426
[TBL] [Abstract][Full Text] [Related]
14. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
Bruserud O; Ulvestad E
Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity.
Jahn B; Bergmann L; Weidmann E; Brieger J; Fenchel K; Schwulera U; Hoelzer D; Mitrou PS
Leuk Res; 1995 Feb; 19(2):73-82. PubMed ID: 7869744
[TBL] [Abstract][Full Text] [Related]
16. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels.
Bruserud O; Ulvestad E
Cancer Immunol Immunother; 2000 Sep; 49(7):377-87. PubMed ID: 10999464
[TBL] [Abstract][Full Text] [Related]
17. Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex.
Ersvaer E; Hampson P; Wendelbo Ø; Lord JM; Gjertsen BT; Bruserud Ø
Hematology; 2007 Jun; 12(3):199-207. PubMed ID: 17558695
[TBL] [Abstract][Full Text] [Related]
18. IL-4, IL-10 and IL-13 in acute myelogenous leukemia.
Bruserud O
Cytokines Cell Mol Ther; 1998 Sep; 4(3):187-98. PubMed ID: 9825844
[TBL] [Abstract][Full Text] [Related]
19. A novel nonradioactive CFDA assay to monitor the cellular immune response in myeloid leukemia.
Yang T; Chen ZZ; Kolb HJ; Buhmann R
Immunobiology; 2013 Apr; 218(4):548-53. PubMed ID: 22883564
[TBL] [Abstract][Full Text] [Related]
20. Lipoteichoic acid derived from Enterococcus faecalis modulates the functional characteristics of both normal peripheral blood leukocytes and native human acute myelogenous leukemia blasts.
Bruserud Ø; Wendelbo Ø; Paulsen K
Eur J Haematol; 2004 Nov; 73(5):340-50. PubMed ID: 15458513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]